Status:
NOT_YET_RECRUITING
An Open Label Trial Assessing the Impact of a Hydration Formula on Overall Health
Lead Sponsor:
Radicle Science
Conditions:
Hydration
Eligibility:
All Genders
21-105 years
Phase:
NA
Brief Summary
An Open Label Trial Assessing the Impact of a Hydration Formula on Overall Health
Detailed Description
This is an open label study conducted with adult participants residing in the United States. Eligible participants will (1) agree to consume a hydration product, (2) agree not to take any other hydra...
Eligibility Criteria
Inclusion
- 1 Inclusion
- Participants must meet all the following criteria:
- Adults, at least 21 years of age at the time of electronic consent, inclusive of all ethnicities, races.
- Resides in the United States.
- 2 Exclusion
- Individuals who report any of the following during screening will be excluded from participation:
- Report being pregnant, trying to become pregnant, or breastfeeding.
- Unable to provide a valid US shipping address and mobile phone number
- Unable to read and understand English.
- Reports a current and/or recent (up to 3 months ago) major illness and/or surgery that poses a known, significant safety risk.
- Reports a diagnosis of cardiac dysfunction, liver or kidney disease that presents a known contraindication and/or a significant safety risk with any of the study product ingredients.
- NYHA Class III or IV congestive heart failure, atrial fibrillation, uncontrolled arrhythmias, cirrhosis, end-stage liver disease, stage 3b or 4 chronic kidney disease, or kidney failure.
- Reports taking medications that have a well-established moderate or severe interaction, posing a substantial safety risk with any of the study product ingredients.
- Anticoagulants, antihypertensives, anxiolytics, antidepressants, chemotherapy, immunotherapy, sedative hypnotics, seizure medications, medications that warn against grapefruit consumption, corticosteroids at doses greater than 5 mg per day, diabetic medications, oral anti-infectives (antibiotics, antifungals, antivirals) to treat an acute infection, antipsychotics, MAOIs, or thyroid products.
- Reports the current use of electrolyte and/or hydration supplements that may limit the effects of the study products.
- Lack of reliable daily access to the internet.
Exclusion
Key Trial Info
Start Date :
September 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
660 Patients enrolled
Trial Details
Trial ID
NCT07206979
Start Date
September 30 2025
End Date
September 30 2026
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radicle Science Inc.
Del Mar, California, United States, 92014